| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Casamento Charles J is a Director at Eton Pharmaceuticals, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $33.63 | $100,897.80 | -7.0% | |
| Jan 4, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $32.11 | $96,341.70 | -12.0% | |
| Dec 1, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $35.74 | $107,219.10 | -10.7% | |
| Nov 2, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $30.29 | $90,863.70 | -5.8% | |
| Oct 1, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $37.99 | $113,955.60 | -5.4% | |
| Sep 1, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $34.74 | $104,206.80 | -5.2% | |
| Aug 3, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $35.74 | $107,213.40 | -8.1% | |
| Jul 1, 2020 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $43.89 | $131,677.20 | -7.5% | |
| Aug 9, 2019 | ETON Eton Pharmaceuticals, Inc. | Director | Buy | 3,500 | $6.11 | $21,369.95 | +5.1% | |
| Dec 28, 2018 | GRDX Gridai Technologies Corp. | Director | Buy | 9,000 | $1.41 | $12,690.00 | +18.9% |